These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 32590773)

  • 1. The role of an antibiotic envelope in the prevention of major cardiac implantable electronic device infections: A systematic review and meta-analysis.
    Asbeutah AAA; Salem MH; Asbeutah SA; Abu-Assi MA
    Medicine (Baltimore); 2020 Jun; 99(26):e20834. PubMed ID: 32590773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The World-wide Randomized Antibiotic Envelope Infection Prevention (WRAP-IT) trial: Long-term follow-up.
    Mittal S; Wilkoff BL; Kennergren C; Poole JE; Corey R; Bracke FA; Curnis A; Addo K; Martinez-Arraras J; Issa ZF; Redpath C; Moubarak J; Khelae SK; Boersma LVA; Korantzopoulos P; Krueger J; Lande JD; Morss GM; Seshadri S; Tarakji KG
    Heart Rhythm; 2020 Jul; 17(7):1115-1122. PubMed ID: 32087357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibacterial Envelope to Prevent Cardiac Implantable Device Infection.
    Tarakji KG; Mittal S; Kennergren C; Corey R; Poole JE; Schloss E; Gallastegui J; Pickett RA; Evonich R; Philippon F; McComb JM; Roark SF; Sorrentino D; Sholevar D; Cronin E; Berman B; Riggio D; Biffi M; Khan H; Silver MT; Collier J; Eldadah Z; Wright DJ; Lande JD; Lexcen DR; Cheng A; Wilkoff BL;
    N Engl J Med; 2019 May; 380(20):1895-1905. PubMed ID: 30883056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of antibiotic envelopes to prevent cardiac implantable electronic device infections: A meta-analysis.
    Koerber SM; Turagam MK; Winterfield J; Gautam S; Gold MR
    J Cardiovasc Electrophysiol; 2018 Apr; 29(4):609-615. PubMed ID: 29364546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-Effectiveness of an Antibacterial Envelope for Cardiac Implantable Electronic Device Infection Prevention in the US Healthcare System From the WRAP-IT Trial.
    Wilkoff BL; Boriani G; Mittal S; Poole JE; Kennergren C; Corey GR; Krahn AD; Schloss EJ; Gallastegui JL; Pickett RA; Evonich RF; Roark SF; Sorrentino DM; Sholevar DP; Cronin EM; Berman BJ; Riggio DW; Khan HH; Silver MT; Collier J; Eldadah Z; Holbrook R; Lande JD; Lexcen DR; Seshadri S; Tarakji KG
    Circ Arrhythm Electrophysiol; 2020 Oct; 13(10):e008503. PubMed ID: 32915063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized Trial of Stand-Alone Use of the Antimicrobial Envelope in High-Risk Cardiac Device Patients.
    Ellis CR; Greenspon AJ; Andriulli JA; Gould PA; Carillo RG; Kolek MJ; Donegan R; Amaral AP; Mittal S
    Circ Arrhythm Electrophysiol; 2023 May; 16(5):e011740. PubMed ID: 36960716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retrospective comparative analysis of cardiovascular implantable electronic device infections with and without the use of antibacterial envelopes.
    Hassoun A; Thottacherry ED; Raja M; Scully M; Azarbal A
    J Hosp Infect; 2017 Mar; 95(3):286-291. PubMed ID: 28131641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of the antibacterial envelope to prevent cardiac implantable electronic device infection in a high-risk population.
    Chaudhry U; Borgquist R; Smith JG; Mörtsell D
    Europace; 2022 Dec; 24(12):1973-1980. PubMed ID: 35989511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Cardiac Implantable Electronic Device Infection: A Clinical and Economic Analysis of the WRAP-IT Trial.
    Wilkoff BL; Boriani G; Mittal S; Poole JE; Kennergren C; Corey GR; Love JC; Augostini R; Faerestrand S; Wiggins SS; Healey JS; Holbrook R; Lande JD; Lexcen DR; Willey S; Tarakji KG;
    Circ Arrhythm Electrophysiol; 2020 May; 13(5):e008280. PubMed ID: 32281393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibacterial Envelope Is Associated With Low Infection Rates After Implantable Cardioverter-Defibrillator and Cardiac Resynchronization Therapy Device Replacement: Results of the Citadel and Centurion Studies.
    Henrikson CA; Sohail MR; Acosta H; Johnson EE; Rosenthal L; Pachulski R; Dan D; Paladino W; Khairallah FS; Gleed K; Hanna I; Cheng A; Lexcen DR; Simons GR
    JACC Clin Electrophysiol; 2017 Oct; 3(10):1158-1167. PubMed ID: 29759500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infectious consequences of hematoma from cardiac implantable electronic device procedures and the role of the antibiotic envelope: A WRAP-IT trial analysis.
    Tarakji KG; Korantzopoulos P; Philippon F; Biffi M; Mittal S; Poole JE; Kennergren C; Lexcen DR; Lande JD; Seshadri S; Wilkoff BL
    Heart Rhythm; 2021 Dec; 18(12):2080-2086. PubMed ID: 34280568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Presentation, Timing, and Microbiology of CIED Infections: An Analysis of the WRAP-IT Trial.
    Sohail MR; Corey GR; Wilkoff BL; Poole JE; Mittal S; Kennergren C; Greenspon AJ; Cheng A; Lande JD; Lexcen DR; Tarakji KG
    JACC Clin Electrophysiol; 2021 Jan; 7(1):50-61. PubMed ID: 33478712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotic prophylaxis based on individual infective risk stratification in cardiac implantable electronic device: the PRACTICE study.
    Malagù M; Vitali F; Brieda A; Cimaglia P; De Raffele M; Tazzari E; Musolino C; Balla C; Serenelli M; Cultrera R; Rapezzi C; Bertini M
    Europace; 2022 Mar; 24(3):413-420. PubMed ID: 34487163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of an antibacterial envelope is associated with reduced cardiac implantable electronic device infections in high-risk patients.
    Kolek MJ; Dresen WF; Wells QS; Ellis CR
    Pacing Clin Electrophysiol; 2013 Mar; 36(3):354-61. PubMed ID: 23252988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibiotic envelope is associated with reduction in cardiac implantable electronic devices infections especially for high-power device-Systematic review and meta-analysis.
    Pranata R; Tondas AE; Vania R; Yuniadi Y
    J Arrhythm; 2020 Feb; 36(1):166-173. PubMed ID: 32071636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Economic evaluation of an absorbable antibiotic envelope for prevention of cardiac implantable electronic device infection.
    Rennert-May E; Raj SR; Leal J; Exner DV; Manns BJ; Chew DS
    Europace; 2021 May; 23(5):767-774. PubMed ID: 33554239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The utility of postoperative systemic antibiotic prophylaxis following cardiovascular implantable electronic device implantation: A systematic review and meta-analysis.
    Chesdachai S; Go JR; Hassett LC; Baddour LM; DeSimone DC
    Pacing Clin Electrophysiol; 2022 Aug; 45(8):940-949. PubMed ID: 35819103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proposal for a Novel Score to Determine the Risk of Cardiac Implantable Electronic Device Infection.
    Calderón-Parra J; Sánchez-Chica E; Asensio-Vegas Á; Fernández-Lozano I; Toquero-Ramos J; Castro-Urda V; Royuela-Vicente A; Ramos-Martínez A
    Rev Esp Cardiol (Engl Ed); 2019 Oct; 72(10):806-812. PubMed ID: 30340923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative checklist to reduce the risk of cardiac implantable electronic device infections.
    Ziacchi M; Massaro G; Angeletti A; Statuto G; Diemberger I; Martignani C; Galiè N; Biffi M; Boriani G
    Pacing Clin Electrophysiol; 2022 Feb; 45(2):262-269. PubMed ID: 34927271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. REducing INFectiOns thRough Cardiac device Envelope: insight from real world data. The REINFORCE project.
    Ziacchi M; Biffi M; Iacopino S; di Silvestro M; Marchese P; Miscio F; Caccavo VP; Zanotto G; Tomasi L; Dello Russo A; Donazzan L; Boriani G
    Europace; 2023 Nov; 25(11):. PubMed ID: 37490930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.